Ardelyx
ARDXDrugs in Pipeline
9
Phase 3 Programs
6
Upcoming Catalysts
2
Next Catalyst
Jun 1, 2026
14wMarket Overview
Stock performance and key metrics
2 upcoming, 0 past
Tenapanor 5 mg BID
Chronic Idiopathic Constipation (CIC)
Sevelamer Carbonate
Hyperphosphatemia
Tenapanor
Hyperphosphatemia
Phosphate Binder Agents
Hyperphosphatemia
AZD1722
Chronic Kidney Disease
Tenapanor 50 MG
Irritable Bowel Syndrome With Constipation (IBS-C)
RDX5791
Constipation Predominant Irritable Bowel Syndrome
AZD1722 (in-patient)
End Stage Renal Disease
RDX013
Hyperkalemia
| Drug Name | Phase | Indication | Designations |
|---|---|---|---|
Tenapanor 5 mg BID | Phase 3 | Chronic Idiopathic Constipation (CIC) | - |
Sevelamer Carbonate | Phase 3 | Hyperphosphatemia | - |
Tenapanor | Phase 3 | Hyperphosphatemia | - |
Phosphate Binder Agents | Phase 3 | Hyperphosphatemia | - |
AZD1722 | Phase 3 | Chronic Kidney Disease | - |
Tenapanor 50 MG | Phase 3 | Irritable Bowel Syndrome With Constipation (IBS-C) | - |
RDX5791 | Phase 2 | Constipation Predominant Irritable Bowel Syndrome | - |
AZD1722 (in-patient) | Phase 2 | End Stage Renal Disease | - |
RDX013 | Phase 2 | Hyperkalemia | - |